News Related News

Singularity University Announces New and Updated Programs to Prepare Leaders for Disruptive Times, Identify Strategic Opportunities, Achieve High-impact Growth, and Build a Better World

SU Redefines the Roadmap to the Future for Enterprises, Startups, and Change Agents MOUNTAIN VIEW, CA – August 17, 2017 – Singularity University (SU), a global community with a mission to educate, inspire, and empower leaders to apply exponential technologies to address [...]

eGenesis Study Addressing Cross-Species Viral Transmission Concern in Xenotransplantation Published in Science

First Pigs without Active Porcine Endogenous Retrovirus (PERV) Produced Using CRISPR-Cas9 Genome Editing Technology – a Landmark Advance for Xenotransplantation Eliminating PERV Establishes a Foundation for Safe Xenotransplantation August 10, 2017 02:00 PM Eastern Daylight Time CAMBRIDGE, Mass.--(BUSINESS WIRE)--eGenesis, [...]

By | August 16th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Modern Meadow Moves Headquarters into state of the art facility in New Jersey

Modern Meadow is relocating its headquarters to Nutley, New Jersey. The biofabrication company will also establish a design and applied research studio at New Lab in Brooklyn. New York, NY, August 14th, 2017 – Modern Meadow, the biofabrication company pioneering biologically [...]

Embryonic Editing Therapies Still Seem Unlikely Despite CRISPR Progress

After it was revealed in a pre-publication scoop three weeks ago by the MIT Technology Review, the news media has extensively covered a story about an Oregon research team’s use of the CRISPR gene editing technique to correct a disease-causing [...]

By | August 16th, 2017|BioPharma & Healthcare, News, Therapeutics|

Four Reasons to Attend Synthetic Biology Conference SynBioBeta SF 2017

Synthetic Biology Conference The premier annual conference for the synthetic biology industry is fast approaching!  The excitement is building for SynBioBeta San Francisco 2017, where more than 600 people will gather from around the world to keep up to [...]

By | August 15th, 2017|News|

Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research

SAN DIEGO, August 14, 2017 -- /PRNewswire/ -- Synthorx Inc., a biotechnology company using synthetic biology to discover and develop novel protein therapeutics, announced today the appointment of Marcos Milla, Ph.D. as senior vice president of research. “Marcos is an [...]

By | August 15th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|